• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Report of sequential interventions at a tertiary cancer centre to reduce acute kidney injury rates following concurrent cisplatin with radiotherapy for head and neck cancer

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Portner, Robin
    Gaito, Simona
    Garcez, Kate
    Lee, Lip W
    Mais, Kathleen L
    Price, James
    Sykes, Andrew J
    Thomson, David J
    McPartlin, Andrew J
    Affiliation
    The Christie NHS Foundation Trust, Department of Head and Neck Cli, Manchester, UK
    Issue Date
    2021
    
    Metadata
    Show full item record
    Abstract
    Introduction: Standard of care Cisplatin chemoradiation (CRT) for head and neck cancer cancers (HNC) improves outcomes, but has associated risk of acute kidney injury (AKI). Various interventions have been proposed to reduce this risk. We report the effects of sequential changes in practice at a tertiary oncology centre introduced to reduce the incidence of AKI and reviewed in a repeated assessment cycle. Materials and Methods: AKI rates was assessed for three patient cohorts receiving concurrent cisplatin with radiotherapy from April 2016 to February 2020. AKI Stage 1 was defined as a rise in creatinine more than 1.5 times baseline or >26 umol/l in 48 hr, Stage 2 as doubled and Stage 3 as triple baseline creatinine. All patients received cisplatin 100 mg/m2 in 1L NaCL on D1 and D22 of a six week radiotherapy course. This was given overnight with 1L Nacl pre-hydration and 2L NaCl post cisplatin administration. Initially patients had a baseline nuclear medicine GFR (if <60 ml/min cisplatin was omitted) and then renal function checked prior to cycle 2 cisplatin, unless concerns about fluid intake. From cohort 2 all patients were mandated to undergo weekly blood tests during treatment regardless of symptoms or oral intake and a pre-chemotherapy review was initiated including recording of stopping all nephrotoxic medications prior to treatment. For cohort 3 mannitol 10% 120 ml added to the chemotherapy regime which otherwise remained unchanged. Results: A total of 136, 39 and 50 patients were audited in cohort 1,2 and 3 respectively. Patient and disease characteristics were well matched in each group. The number of patients suffering any AKI during treatment fell from 38% to 26% over the period, despite increased frequency of monitoring. AKI stage I fell from 27% to 18% and severe AKI stage III incidence fell from 5% to 0%. Admission rates for management of AKI dropped by almost two thirds, from 34% to 18%, and then 12% in each successive cohort. Conclusions: This study has demonstrated that the sequential adoption of simple evidence based interventions to reduce the incidence of AKI during CTRT with cisplatin can have a significant benefit to patient outcomes, reducing treatment related nephrotoxicity and requirement for inpatient management. Despite this one in four patients continues to suffer AKI during therapy highlighting the need for meticulous management of this patient group.
    Citation
    Portner R, Gaito S, Garcez K, Lee L, Mais K, Price J, et al. Report of sequential interventions at a tertiary cancer centre to reduce acute kidney injury rates following concurrent cisplatin with radiotherapy for head and neck cancer. Oral Oncology. 2021;118.
    Journal
    Oral Oncology
    URI
    http://hdl.handle.net/10541/624424
    Type
    Meetings and Proceedings
    Language
    en
    Collections
    All Christie Publications

    entitlement

     
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.